Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

RBMY1A Inhibitors

RBMY1A inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of the RBMY1A protein, which is part of the RNA-binding motif protein, Y-linked, family. RBMY1A is known to play a crucial role in RNA processing, particularly in the regulation of alternative splicing events during spermatogenesis. This protein is predominantly expressed in the testes and is involved in the proper development and function of sperm cells by influencing the splicing of pre-mRNAs that are critical for germ cell maturation. Inhibitors of RBMY1A are developed to interfere with its RNA-binding capabilities or its interactions with other components of the splicing machinery, thereby disrupting its role in the regulation of gene expression at the RNA level.

The development of RBMY1A inhibitors involves an in-depth understanding of the protein's structure, particularly its RNA recognition motifs and other domains involved in protein-protein interactions. Structural biology techniques, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, are used to elucidate the three-dimensional structure of RBMY1A. This structural information is essential for identifying potential binding sites where inhibitors can interact with the protein to block its function. Computational methods, including molecular docking and virtual screening, are employed to identify small molecules that can specifically bind to these sites with high affinity. Once potential inhibitors are identified, they are synthesized and subjected to in vitro assays to assess their binding properties, specificity, and inhibitory potency. Through iterative cycles of optimization, these inhibitors are refined to improve their effectiveness and stability. The study of RBMY1A inhibitors provides valuable insights into the protein's role in RNA processing and spermatogenesis, contributing to a broader understanding of the molecular mechanisms that govern gene expression regulation and cellular differentiation within reproductive biology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wiskostatin

253449-04-6sc-204399
sc-204399A
sc-204399B
sc-204399C
1 mg
5 mg
25 mg
50 mg
$49.00
$124.00
$441.00
$828.00
4
(1)

Glucose transporter 1 (GLUT1) inhibitor, potentially affecting glucose metabolism pathways linked to RBMY1A.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

PARP inhibitor, might influence DNA repair pathways, indirectly affecting RBMY1A's function in cell cycle regulation.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Modulator of NF-κB pathway, potentially affecting transcriptional regulation where RBMY1A is involved.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

Bromodomain inhibitor, can affect chromatin remodeling and gene expression linked to RBMY1A activity.

PF-562271

717907-75-0sc-478488
sc-478488A
sc-478488B
5 mg
10 mg
50 mg
$312.00
$474.00
$1124.00
3
(1)

FAK/Pyk2 inhibitor, potentially modifying cell adhesion and migration pathways associated with RBMY1A.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

Bcl-2 inhibitor, might influence apoptotic pathways, potentially impacting RBMY1A-mediated cell survival.

Dabrafenib

1195765-45-7sc-364477
sc-364477A
sc-364477B
sc-364477C
sc-364477D
5 mg
25 mg
50 mg
100 mg
10 g
$141.00
$260.00
$278.00
$411.00
$12485.00
6
(1)

BRAF inhibitor, could affect MAPK/ERK signaling, indirectly modulating RBMY1A's role in this pathway.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

CDK4/6 inhibitor, might modulate cell cycle pathways where RBMY1A is implicated.

Torin 1

1222998-36-8sc-396760
10 mg
$245.00
7
(1)

mTOR inhibitor, potentially affecting protein synthesis and autophagy processes linked to RBMY1A.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

ROCK inhibitor, can influence cytoskeletal dynamics, potentially affecting RBMY1A's role in cell morphology.